Global Health Limited, which runs the Medanta network of multi-specialty hospitals across North and East India, reported a strong rise in patient activity and revenue in Q3 FY26, even as investments in new hospitals and regulatory changes weighed on short-term profit.
The company’s consolidated total income grew 19.1% year-on-year to ₹11,428 million during the December 2025 quarter, reflecting a steady rise in people seeking both inpatient and outpatient care. Inpatient volumes increased 14.3%, while outpatient footfalls jumped 19.5%, underlining sustained demand for tertiary healthcare. Average revenue per occupied bed rose nearly 10% to ₹67,361, supported by improved case mix and shorter hospital stays.
Behind these numbers is Medanta’s newest hospital in Noida, which completed its first full quarter of operations. The facility added modern operating theatres, cath labs and advanced medical equipment, onboarded over 70 doctors, and contributed ₹343 million in revenue, though it posted an EBITDA loss of ₹320 million as operations scale up.
Profit after tax for the quarter stood at ₹950 million, impacted by initial losses at Noida and a one-time ₹366 million charge linked to new Labour Codes. Over the first nine months of FY26, Medanta added 537 beds, grew international patient revenue by over 37%, and delivered an 8.5% rise in profit—signalling long-term growth built on expanding access to quality healthcare.
